These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30423020)

  • 1. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
    Zhu W; Reuter S; Field LJ
    Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.
    Zhu W; Zhang W; Shou W; Field LJ
    Cardiovasc Res; 2014 Jul; 103(1):81-9. PubMed ID: 24812279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload.
    Toischer K; Zhu W; Hünlich M; Mohamed BA; Khadjeh S; Reuter SP; Schäfer K; Ramanujam D; Engelhardt S; Field LJ; Hasenfuss G
    J Clin Invest; 2017 Dec; 127(12):4285-4296. PubMed ID: 29083322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy.
    Chen J; Wei J; Xia P; Liu Y; Belew MD; Toohill R; Wu BJ; Cheng Z
    Cardiovasc Res; 2024 Jul; 120(9):1024-1036. PubMed ID: 38646672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
    Matsumura N; Zordoky BN; Robertson IM; Hamza SM; Parajuli N; Soltys CM; Beker DL; Grant MK; Razzoli M; Bartolomucci A; Dyck JRB
    Cardiovasc Res; 2018 Aug; 114(10):1350-1359. PubMed ID: 29566148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Cycle-Mediated Cardiac Regeneration in the Mouse Heart.
    Eghbali A; Dukes A; Toischer K; Hasenfuss G; Field LJ
    Curr Cardiol Rep; 2019 Sep; 21(10):131. PubMed ID: 31529165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
    Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
    J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.
    Bai Y; Chen Q; Sun YP; Wang X; Lv L; Zhang LP; Liu JS; Zhao S; Wang XL
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28636290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heat shock protein 27 attenuated doxorubicin-induced myocardial damage by reducing cardiomyocyte apoptosis, mitochondria damage and protein carbonylation].
    Liu L; Zhang XJ; Qian B; Min XY; Cheng YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1021-6. PubMed ID: 19102918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.
    Wang Y; Lei T; Yuan J; Wu Y; Shen X; Gao J; Feng W; Lu Z
    Redox Biol; 2018 Jul; 17():25-34. PubMed ID: 29660505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.
    Zhu W; Soonpaa MH; Chen H; Shen W; Payne RM; Liechty EA; Caldwell RL; Shou W; Field LJ
    Circulation; 2009 Jan; 119(1):99-106. PubMed ID: 19103993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
    Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
    Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
    Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
    Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC.
    Xu F; Zang T; Chen H; Zhou C; Wang R; Yu Y; Shen L; Qian J; Ge J
    Cell Signal; 2024 Jan; 113():110937. PubMed ID: 37871668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction.
    Hassink RJ; Pasumarthi KB; Nakajima H; Rubart M; Soonpaa MH; de la Rivière AB; Doevendans PA; Field LJ
    Cardiovasc Res; 2008 Apr; 78(1):18-25. PubMed ID: 18079102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
    Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J
    Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).
    Cheng Z; DiMichele LA; Rojas M; Vaziri C; Mack CP; Taylor JM
    J Mol Cell Cardiol; 2014 Feb; 67():1-11. PubMed ID: 24342076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.